This resource aims to support AIDS Drug Assistance Programs (ADAPs) in establishing clear 340B discount right-of-way expectations, policies, and processes in coordination with other covered entities to ensure that critical program income and/or rebate revenue vital to HIV service delivery in the United States is maximized without the risk of duplication.
On November 16, 2022, NASTAD hosted the third installment of the Social Determinants of Health (SDOH) Legal Series. This webinar focused on housing and legal services, specifically the history and programming of Housing Opportunities for Persons with AIDS (HOPWA).
On October 26, 2022, NASTAD hosted the second installment of the Social Determinants of Health (SDOH) Legal Series discussing HIV Criminalization. NASTAD Health System Integration Senior Manager Dori Molozanov, JD presented on the history, impact, and modernization of HIV criminalization laws. Special guest Adrian Guzman, J.D, MPH also presented on HIV criminalization efforts in the New York City Department of Health and Hygiene.
On September 29, 2022, NASTAD hosted the first installment of the Social Determinants of Health (SDOH) Legal Series. This webinar focused on the impact legislation has on healthcare, programs like Ryan White, Ending the Epidemic (EHE), Medicaid, and Medicare. The webinar ended with PrEP care access case studies and a group discussion.
This infographic discusses how Human Papilloma Virus (HPV) is the most common sexually transmitted infection, and two types of HPV (16 and 18) cause nearly 50% of high-grade cervical pre-cancers. HIV and cervical cancer are inextricably linked. Women living with HIV are six times more likely to develop cervical cancer, which is one of the AIDS-defining illnesses and the most common cancer among women living with HIV globally.
This Funding Opportunity Announcement (FOA) encourages formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention or treatment.
This Funding Opportunity Announcement (FOA) solicits innovative research to optimize HIV prevention and care which is aligned with NIMH Division of AIDS Research (DAR) priorities. Applications may include formative basic behavioral and social science to better understand a step or steps in the HIV prevention or care continuum, and/or the initial development and pilot testing of innovative intervention approaches. Applicants are encouraged to read current Notices of Special Interests (NOSIs) from NIMH DAR for further information about the Divisions research priorities.
This FOA solicits innovative research to optimize HIV prevention and care which is aligned with NIMH Division of AIDS Research (DAR) priorities. Applications may include formative basic behavioral and social science to better understand a step or steps in the HIV prevention or care continuum, and/or the initial development and pilot testing of innovative intervention approaches, and intervention efficacy or effectiveness trials. Applicants are encouraged to read current Notices of Special Interests (NOSIs) from NIMH DAR for further information about the Divisions research priorities.
This webinar built capacity on long-acting therapies, identified potential barriers to access, and discussed what is needed to prepare health systems to best absorb these technologies.
This report, which marks World AIDS Day 2022, unpacks the impact that inequalities have had on the AIDS response.
